REFERENCES
- Afzal , MA , Minor , PD and Schild , GC . (2000) . ‘Clinical safety issues of measles, mumps and rubella vaccines’ . Bulletin of the World Health Organization , 78 (2) : 199 – 202 .
- Beale , AJ . (1998) . ‘Autism, inflammatory bowel disease, and MMR vaccine’, ‘Correspondence’ . Lancet , 351 (21 March) : 906
- Bedford , H , Booy , R , Dunn , D , DiGuiseppi , C , Gibb , D , Gilbert , R , Logan , S , Peckham , C , Roberts , I and Tookey , P . (1998) . ‘Autism, inflammatory bowel disease, and MMR vaccine’, ‘Correspondence’ . Lancet , 351 (21 March) : 907
- Black , D , Prempeh , H and Baxter , T . (1998) . ‘Autism, inflammatory bowel disease, and MMR vaccine’, ‘Correspondence’ . Lancet , 351 (21 March) : 905 – 906 .
- BSE Inquiry Website: www.bse.org.uk
- Hamilton , M . (2001) . ‘The MMR vaccination and autism: a lay person’s contribution' . West Indian Medical Journal , 50 (1) : 87 – 88 .
- Hilleman , MR . (1992) . ‘Past, present, and future of measles, mumps, and rubella virus vaccines’ . Pediatrics , 90 (1) : 149 – 153 .
- Horton , A . (1998) . ‘Autism, inflammatory bowel disease, and MMR vaccine’, ‘Correspondence’, ‘Editor’s reply' . Lancet , 351 (21 March) : 908 – 909 .
- Immunization Procedures, National Health and Medical Research Council (1991) 4th edition. Canberra: Australian Government Publishing Service
- Lee , JW , Meigaard , B , Clements , CJ , Kane , M , Mulholland , EK and Olive , JM . (1998) . ‘Autism, inflammatory bowel disease, and MMR vaccine’, ‘Correspondence’ . Lancet , 351 (21 March) : 905
- Lindley , KJ and Milla , PJ . (1998) . ‘Autism, inflammatory bowel disease, and MMR vaccine’, ‘Correspondence’ . Lancet , 351 (21 March) : 907 – 908 .
- O'Brien , SJ , Jones , IG and Christie , P . (1998) . ‘Autism, inflammatory bowel disease, and MMR vaccine’, ‘Correspondence’ . Lancet , 351 (21 March) : 906 – 907 .
- Payne , C and Mason , B . (1998) . ‘Autism, inflammatory bowel disease, and MMR vaccine’, ‘Correspondence’ . Lancet , 351 (21 March) : 907
- Petit‐Zeman S (2002) ‘Most MMR studies are meaningless, investigation claims’ The Observer 6 October
- The Pharmaceutical Journal (2002)) 269 (7724) 703
- Stock S (2002) ‘No evidence for claims’ The Australian 18 February: 11
- Thompson , KM . (2002) . ‘Variability and uncertainty meet risk management and risk communication’ . Risk Analysis , 22 (3) : 647 – 654 .
- Wakefield , AJ , Murch , SH , Anthony , A , Linnell , J , Casson , DM , Malik , M , Dhillon , AP , Thomson , MA , Harvey , P , Valentine , A , Davies , SE and Walker‐Smith , JA . (1998) . ‘Ileal‐lymphoid‐nodular hyperplasia, non‐ specific colitis, and pervasive developmental disorder in children’ . Lancet , 351 (28 February) : 637 – 641 .
- Walker , C and Jacobs , S . (2002) . ‘Social structures of science and approaches to outcomes‐based medical research’ . Critical Public Health , 12 (4) : 309 – 320 .